Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leon Sun

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Urology|January 16, 2007
Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screeningJudd W Moul, Leon Sun, James M Hotaling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen eraCorey A Carter, Timothy Donahue, Leon Sun, et al.
The Journal of Urology|September 18, 2009
Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen erasLeon Sun, Arthur A Caire, Cary N Robertson, et al.
Cancer|February 18, 2010
Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of deathToni K Choueiri, Ming-Hui Chen, Anthony V D'Amico, et al.
Urology|October 10, 2009
Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75Arthur A Caire, Leon Sun, Cary N Robertson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomyChristopher L Amling, Robert H Riffenburgh, Leon Sun, et al.
The Journal of Urology|May 19, 2010
Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancerLionel L Bañez, Leon Sun, Geert J van Leenders, et al.
The Journal of Urology|June 16, 2009
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomyLionel L Bañez, Leon Sun, Bruce J Trock, et al.
The Journal of Urology|May 19, 2009
Factors predicting prostatic biopsy Gleason sum under gradingDanielle A Stackhouse, Leon Sun, Florian R Schroeck, et al.
Oncology Reports|December 7, 2002
Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissuesAxel S Merseburger, Markus A Kuczyk, Jurgen Serth, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Urology|January 16, 2007
Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screeningJudd W Moul, Leon Sun, James M Hotaling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen eraCorey A Carter, Timothy Donahue, Leon Sun, et al.
The Journal of Urology|September 18, 2009
Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen erasLeon Sun, Arthur A Caire, Cary N Robertson, et al.
Cancer|February 18, 2010
Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of deathToni K Choueiri, Ming-Hui Chen, Anthony V D'Amico, et al.
Urology|October 10, 2009
Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75Arthur A Caire, Leon Sun, Cary N Robertson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomyChristopher L Amling, Robert H Riffenburgh, Leon Sun, et al.
The Journal of Urology|May 19, 2010
Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancerLionel L Bañez, Leon Sun, Geert J van Leenders, et al.
The Journal of Urology|June 16, 2009
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomyLionel L Bañez, Leon Sun, Bruce J Trock, et al.
The Journal of Urology|May 19, 2009
Factors predicting prostatic biopsy Gleason sum under gradingDanielle A Stackhouse, Leon Sun, Florian R Schroeck, et al.
Oncology Reports|December 7, 2002
Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissuesAxel S Merseburger, Markus A Kuczyk, Jurgen Serth, et al.
Pageof 10